Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT05838183

Interstitial Lung Disease and Obstructive Sleep Apnea

Led by Dan Liu · Updated on 2026-02-10

70

Participants Needed

1

Research Sites

382 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Clinically, all patients with interstitial lung disease(ILD) were observed, and relevant clinical data were collected. Bronchoscopic specimens were collected according to the condition of the enrolled patients, and the rapid on site evaluation(ROSE) was evaluated, combined with the metagenomic next generation sequencing(mNGS) results of these patients. To observe the etiology and biological characteristics of exacerbation in patients with interstitial lung disease. All patients undergo polysomnography (PSG) and drug-induced sleep endoscopy(DISE). The biological specimens was obtained for molecular biology or other tests.We detected ZNF331, Claudin1, Claudin2, Claudin3, Claudin4, and IL22 as biomarkers to differentiate the diagnostic efficiency of OSA in ILD, ILD+OSA, OSA, and Ctrl groups, respectively

CONDITIONS

Official Title

Interstitial Lung Disease and Obstructive Sleep Apnea

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Over 18 years old and under 80 years old
  • Clinical diagnosis of interstitial lung disease or obstructive respiratory sleep apnea syndrome
  • Patient is conscious and capable of signing informed consent
  • Patient can wear a polysomnograph for monitoring
Not Eligible

You will not qualify if you...

  • Malignant tumors
  • Severe heart failure
  • Uremia
  • Autoimmune diseases
  • Pulmonary embolism and end-stage chronic obstructive pulmonary disease
  • Mental illness that prevents signing informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tianjin Medical University General Hospital

Tianjin, China, 300000

Actively Recruiting

Loading map...

Research Team

D

Dan Liu

CONTACT

J

Jing Feng

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here